Marker Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MRKR and other ETFs, options, and stocks.

About MRKR

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX. 

CEO
Juan F. Vera
CEOJuan F. Vera
Employees
8
Employees8
Headquarters
Houston, Texas
HeadquartersHouston, Texas
Founded
1991
Founded1991
Employees
8
Employees8

MRKR Key Statistics

Market cap
39.17M
Market cap39.17M
Price-Earnings ratio
-2.29
Price-Earnings ratio-2.29
Dividend yield
—
Dividend yield—
Average volume
15.93K
Average volume15.93K
High today
$4.59
High today$4.59
Low today
$4.40
Low today$4.40
Open price
$4.50
Open price$4.50
Volume
9.94K
Volume9.94K
52 Week high
$9.68
52 Week high$9.68
52 Week low
$0.76
52 Week low$0.76
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.